Subsequently, we investigated the in vivo effects of combination therapy with DAC (intraperitoneal injection) followed by the adoptive transfer of ex vivo expanded human γδ T cells (intravenous injection) in immunocompromised NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) mice bearing H1299 human lung cancer xenografts (Fig. 6a). The gene discussed is CTSG; the disease is lung carcinoma.